Exchange: NASDAQ·Updated 07:58 PM EDT
GOVX logo

GOVX Geovax Labs Inc

$0.721
$0.004
(0.56%)
Today
Closed $0.721
$0.081
(11.23%)
After Hours
Reported EarningsNov 13
Mkt Cap$5.31M
Vol744,466.00

About GOVX

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola-Zaire, Ebola-Sudan, Lassa, Marburg, Zika virus and malaria. The company was founded in June 1988 and is headquartered in Smyrna, GA.
53

Neutral Sentiment

How do you feel about GOVX?

Advertisement|Remove ads.